PyInvesting

Market research

600998.SHG Jointown Pharmaceutical Group Co., Ltd

SHG CNY Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
25B
P/E ratio
12.62
Analyst target
5.86
Dividend yield
4.1%
Beta
0.13

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Jointown Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 13.6% below its 200 day moving average.

From a valuation standpoint, the stock is 96.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.

Jointown Pharmaceutical Group Co., Ltd's total revenue rose by 16.1% to $29B since the same quarter in the previous year.

Its net income has increased by 220.4% to $882M since the same quarter in the previous year.

Finally, its free cash flow grew by 850.9% to $799M since the same quarter in the previous year.

Based on the above factors, Jointown Pharmaceutical Group Co., Ltd gets an overall score of 4/5.